
Clinical Trials
Supported by ForeBatten
OUR COMMITMENT TO THE CLN3 BATTEN COMMUNITY
At ForeBatten, we believe hope isn’t passive.
Hope is not just wishing for change.
Hope is taking action to create it.
We are using the same dedicated team and the roadmap we built to move toward a clinical trial for juvenile Batten disease.
We are applying for grants.
We are funding the necessary studies.
We are pushing forward.
Zebronkysen is a story of perseverance.
But it’s also part of something bigger.
Project Four Leaf Clover is that bigger movement.
It’s putting hope into action —
so that future children diagnosed with Batten can access treatment earlier,
and families like ours don’t have to fight this hard just to get a chance.
We are closer than we’ve ever been.
And we are not stopping.
